Skip to content
OpenCapital
Get started

Insulet PODD Drug Delivery — Total Revenue

Other product segments

Total Omnipod products
$758.4M+36.9%
International
$242.9M+59.5%

Similar metrics at other companies

West Pharmaceutical Services logo
WSTDelivery Systems — Revenue
$144.9M+20.8%
Baxter International logo
BAXMedication Delivery — Net Sales
$761M+7.2%
Baxter International logo
BAXMedication Delivery — Revenue
$683.75M-2.3%
Medtronic logo
MDTOther Operating Segments, Including Diabetes — Net Sales
$811.75M+12.3%
Baxter International logo
BAXInfusion Therapies & Technologies — Net Sales
$981M-1.3%
West Pharmaceutical Services logo
WSTHigh-Value Product Delivery Devices — Percentage of net sales
3.3%—

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's drug delivery — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's drug delivery — total revenue?
Insulet (PODD) reported drug delivery — total revenue of $3.3M in Q1 2026.
How has Insulet's drug delivery — total revenue changed year-over-year?
Insulet's drug delivery — total revenue decreased by 77.9% year-over-year, from $14.9M to $3.3M.
What is the long-term trend for Insulet's drug delivery — total revenue?
Over 4 years (2021 to 2025), Insulet's drug delivery — total revenue has grown at a -21.0% compound annual growth rate (CAGR), from $87.4M to $34.1M.
What does drug delivery — total revenue mean?
Total revenue generated from providing specialized drug delivery technology and services to third-party pharmaceutical partners.
How do you interpret drug delivery — total revenue?
An increase indicates successful partnership expansion or higher utilization of the company's delivery technology by pharmaceutical clients, while a decrease may signal contract expirations or reduced demand for the specific delivery platform.
How does drug delivery — total revenue compare across companies?
Comparable to contract manufacturing or technology licensing revenue streams in other medical device or biotechnology firms that provide delivery hardware to pharmaceutical partners.